Pluri Inc. Increase (Decrease) in Other Operating Assets and Liabilities, Net
Pluri Inc. (PLUR) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of -$1.46 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-09-10
- Pluri Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-30 was -$630.00K.
- Pluri Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was -$384.00K, a 773.68% decline year-over-year.
- Pluri Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was -$356.00K.
- Pluri Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was -$88.00K.
- Pluri Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2026 was -$1.46M.
- Pluri Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was -$834.00K.
- Pluri Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was -$285.00K.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$630.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | -$1.01M derived: sum of 2 quarters · filed 2026-09-10 | -$1.37M derived: sum of 3 quarters · filed 2026-09-10 | -$1.46M 10-K · filed 2026-09-10 |
| 2026-03-31 | -$384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | -$740.00K derived: sum of 2 quarters · filed 2026-05-14 | -$828.00K 10-Q · filed 2026-05-14 | -$1.48M derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-12-31 | -$356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$444.00K 10-Q · filed 2026-02-12 | -$1.10M derived: sum of 3 quarters · filed 2026-09-10 | -$1.04M derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-09-30 | -$88.00K 10-Q · filed 2025-11-12 | -$744.00K derived: sum of 2 quarters · filed 2026-09-10 | -$687.00K derived: sum of 3 quarters · filed 2026-09-10 | -$835.00K derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-06-30 | -$656.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | -$599.00K derived: sum of 2 quarters · filed 2026-09-10 | -$747.00K derived: sum of 3 quarters · filed 2026-09-10 | -$834.00K 10-K · filed 2026-09-10 |
| 2025-03-31 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | -$91.00K derived: sum of 2 quarters · filed 2026-05-14 | -$178.00K 10-Q · filed 2026-05-14 | -$338.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$235.00K 10-Q · filed 2026-02-12 | -$395.00K derived: sum of 3 quarters · filed 2026-02-12 | -$545.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | -$87.00K 10-Q · filed 2025-11-12 | -$247.00K derived: sum of 2 quarters · filed 2025-11-12 | -$397.00K derived: sum of 3 quarters · filed 2025-11-12 | -$513.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | -$310.00K derived: sum of 2 quarters · filed 2025-09-17 | -$426.00K derived: sum of 3 quarters · filed 2025-09-17 | -$285.00K 10-K · filed 2025-09-17 |
| 2024-03-31 | -$150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | -$266.00K derived: sum of 2 quarters · filed 2025-05-13 | -$125.00K 10-Q · filed 2025-05-13 | |
| 2023-12-31 | -$116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | $25.00K 10-Q · filed 2025-02-11 | ||
| 2023-09-30 | $141.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |